Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
Please provide your email address to receive an email when new articles are posted on . A pulsed field ablation technology was safe at 30 days in a real-world population of patients with atrial ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) ...
A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...
Researchers found no significant difference in recurring a-fib in men compared to women after pulsed field ablation. Photo by fernando zhiminaicela/Pixabay A procedure to treat the irregular heart ...
Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...
- Funding will advance US and EU clinical studies of innovative pulsed field ablation system for treating atrial fibrillation - Argá Medtech’s CSE™ ablation system enables electrophysiologists to ...
Collateral effects on non-target tissue are worse with pulsed-field ablation than with radiofrequency ablation, according to a study published April 24 in JACC: Clinical Electrophysiology. The ...
Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified interim analysis IRVINE, Calif., Feb. 3, 2023 /PRNewswire/ -- Biosense ...
Just because pulsed field ablation therapy has yet to make its mark in the U.S. by clearing the FDA, that doesn’t mean there’s any reason to wait on developing version 2.0. Field Medical is already ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window AMSTERDAM -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results